Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02653287 · ClinicalTrials.gov registry record · NA
Lupus Intervention for Fatigue Trial
A NA study of Physical Activity and Fatigue, sponsored by Northwestern University.
- Active
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 2
- Study locations
NCT02653287: Active NA study of Physical Activity and Fatigue, sponsored by Northwestern University.
NCT02653287 is a NA study of Physical Activity and Fatigue that is active but no longer recruiting, run by Northwestern University. The registered enrollment target is 200 participants, below the 357-participant average among 131 other Physical Activity trials with a reported enrollment target (44% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02653287, a NA study of Physical Activity and Fatigue, is active but no longer recruiting, sponsored by Northwestern University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 2
- Study locations
Study Summary
Participants in the Chicago Lupus Database or individuals seen at Northwestern Medicine will be approached to enroll in a one year clinical trial looking at decreasing fatigue in persons with systemic lupus erythematosus (SLE). The intervention group will receive individual coaching sessions focusing on physical activity and nutrition while the control group will receive individual calls in relation to SLE self-management educational sessions.This study is designed to evaluate the LIFT intervention to decrease fatigue (primary outcome), improve physical activity (secondary outcome) and dietary behavior (exploratory outcome) in persons with SLE.
Primary Outcome
Online questionnaire
Conditions Studied
Interventions
- OTHER Control
- BEHAVIORAL Experimental
Study Locations (2)
Illinois
- Holly Milaeger - Chicago
- Northwestern University - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2019-05-01 |
| Est. Completion | 2025-12 |
| Phase | NA |
What the registry record for NCT02653287 still lists
NCT02653287 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 357-participant average among 131 other Physical Activity trials with a reported enrollment target (44% lower).
The record links to 3 conditions, with Physical Activity appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.
NCT02653287 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT02653287 about?
NCT02653287 is a clinical study titled "Lupus Intervention for Fatigue Trial". Participants in the Chicago Lupus Database or individuals seen at Northwestern Medicine will be approached to enroll in a one year clinical trial looking at decreasing fatigue in persons with systemic lupus erythematosus (SLE). The intervention group will receive individual coaching sessions focusin...
What is the current status of trial NCT02653287?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2019-05-01. Estimated completion is 2025-12.
What conditions does trial NCT02653287 study?
This clinical trial studies the following conditions: Physical Activity, Fatigue, Lupus Erythematosus, Systemic.
What interventions are being tested in trial NCT02653287?
The interventions under investigation include: Control (OTHER), Experimental (BEHAVIORAL).
Who is sponsoring clinical trial NCT02653287?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02653287 being conducted?
This trial has 2 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Physical Activity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02653287's enrollment target sits among peer trials
200 51st of 131 higher than 79 of 131 other Physical Activity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Physical Activity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Heterogeneity of Vascular Adaptations to Exercise With Aging in Women and Men
RECRUITING · NA
-
Goal Setting to Promote Physical Activity Adherence in Midlife Adults
RECRUITING · NA
-
Va Meh Du: A Sports-based Mental Health Promotion Intervention for Karenni Refugees
RECRUITING · NA
-
Teen Mom Study Feasibility Trial
RECRUITING · NA
-
The Fit With Us Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI